Twenty‐five patients with lung cancer were treated with actinomycin‐D and vincristine (V‐D) with only one objective response (IMD). The survival of these patients was compared retrospectively to a group of 49 consecutive patients treated with radiotherapy only during the same time period. Median survival times for the V‐D group and radiotherapy controls were 6.5 and 7.5 months, respectively. It is concluded that V‐D did not increase survival in patients with lung cancer and should be dropped from the chemotherapeutic armamentarium in lung cancer.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Apr 1976|
ASJC Scopus subject areas
- Cancer Research